Company: PRGO
Filing Date: 2025-03-10
Form Type: PRE 14A
Source: 0000950170-25-035751
Chunk: 74

Company: PERRIGO Co plc
Filing Date: 2025-03-10
Form: PRE 14A
Chunk 74
---

 •2021 - March 2024Better Therapeutics (NASDAQ: BTTX)                                                                                                                                                                                                                        
 •2009 - 2022ChemoCentryx (NASDAQ: CCXI)                                                                                                                                                                                                                                     
 •2016 - 2019Genomic Health (NASDAQ: GHDX)                                                                                                                                                                                                                                   
 •2016 - 2017Sunesis Pharmaceuticals (NASDAQ: SNSS)                                                                                                                                                                                                                          
 •Mr. Parker has developed expertise across the healthcare sector through his extensive experience as a senior executive at multiple biotechnology companies, as a board member at multiple healthcare companies and as an investment banker to the healthcare industry.     
 •He brings a unique understanding of trends in the healthcare industry including experience with emerging technologies and regulatory strategies.                                                                                                                           
 •Mr. Parker also provides valuable perspective on areas of financial management and capital allocation. He has extensive capital markets and M&A experience as an experienced chief financial officer across three companies and over twenty years as an investment banker. |

| Jonas SamuelsonIndependent                                             |     |                                                                                |
| Age56Director sinceJanuary, 2025CommitteesAuditNominating & Governance |     | •2016 – January 2025, President & CEO, AB Electrolux                           
 •2011 – 2016, CEO, Major Appliances, Electrolux Europe, Middle East and Africa 
 •2008 – 2011, CFO Electrolux Group                                             
 •2005 – 2008, CFO and EVP, Munters AB                                          
 •2022 - Present:Volvo Car AB (NASDAQ Stockholm: VOLCAR B) People Committee     |

#### PERRIGO•2025 PROXY STATEMENT75
Proposals to be Voted on

<div align='center'>Proposal 1 – Elect eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders</div>

We are asking shareholders to approve the following resolutions as Ordinary Resolutions of the Company at the AGM:

RESOLVEDthat the shareholders elect, by separate resolutions, the following individuals as directors, to serve until the 2026 Annual General Meeting:

Bradley A. Alford

Orlando D. Ashford

Julia M. Brown

Adriana Karaboutis

Jeffrey B. Kindler

Patrick Lockwood-Taylor

Albert A. Manzone

Donal O’Connor

Geoffrey M. Parker

Jonas Samuelson

<div align='center'>The Board of Directors unanimously recommends a vote FOR

each of the director nominees.</div>